Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome

Current Opinion in Neurology

Volumn 25, Issue 2, 2012, Pages 112-124

  Fung, Lawrence K ^a   Quintin, Eve Marie ^a   Haas, Brian W ^a   Reiss, Allan L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fragile X syndrome; Genetic; Neuroimaging; Williams syndrome

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ACAMPROSATE; DICYCLOVERINE; DONEPEZIL; GABOXADOL; MEMANTINE; MICRORNA; OCTAHYDRO 4 HYDROXY 4 [(3 METHYLPHENYL)ETHYNYL] 1H INDOLE 1 CARBOXYLIC ACID METHYL ESTER; RILUZOLE; SCAFFOLD PROTEIN; TROPICAMIDE; VALPROIC ACID;

AMYGDALOID NUCLEUS; BEHAVIOR; BEHAVIOR DISORDER; CELL ADHESION; CHOLINERGIC TRANSMISSION; COGNITION; COGNITIVE DEFECT; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FETUS DEVELOPMENT; FRAGILE X SYNDROME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUSIFORM GYRUS; GABAERGIC TRANSMISSION; GENETIC VARIABILITY; HUMAN; LANGUAGE DEVELOPMENT; LONG TERM POTENTIATION; MOLECULAR BIOLOGY; NERVE CELL PLASTICITY; NERVE GROWTH; NEUROIMAGING; NEUROTRANSMISSION; PARIETAL LOBE; PHENOTYPE; POSTCENTRAL GYRUS; PROTEIN PROCESSING; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SOCIAL BEHAVIOR; WILLIAMS BEUREN SYNDROME;

ANIMALS; CEREBRAL CORTEX; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; FRAGILE X SYNDROME; HUMANS; MICRORNAS; NERVE NET; NEUROIMAGING; SYNAPSES; WILLIAMS SYNDROME;

EID: 84859751262     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328351823c     Document Type: Review

References (137)

1. Freund LS, Reiss AL. Cognitive profiles associated with the fra(X) syndrome in males and females. Am J Med Genet 1991; 38:542-547.
2. Reiss AL, Dant CC. The behavioral neurogenetics of Fragile X syndrome: analyzing gene-brain-behavior relationships in child developmental psy-chopathologies. Dev Psychopathol 2003; 15:927-968. (Pubitemid 351480023)
3. Hall SS, Burns DD, Lightbody AA, Reiss AL. Longitudinal changes in intellectual development in children with Fragile X syndrome. J Abnorm Child Psychol 2008; 36:927-939.
4. Lodish MB, Stratakis CA. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 2010; 24:439-449.
5. Yuhas J, Cordeiro L, Tassone F, et al. Brief report: Sensorimotor gating in idiopathic autism and autism associated with Fragile X syndrome. J Autism Dev Disord 2011; 41:248-253.
6. Roberts JE, Hatton DD, Long AC, et al. Visual attention and autistic behavior in infants with Fragile Xsyndrome.J Autism Dev Disord 2011. [Epub ahead of print]
7. Van der Molen MJ, Van der Molen MW, Ridderinkhof KR, et al. Auditory and visual cortical activity during selective attention in Fragile X syndrome: a cascade of processing deficiencies. Clin Neurophysiol 2011. [Epub ahead of print]
8. Baker S, Hooper S, Skinner M, et al. Working memory subsystems and task complexity in young boys with Fragile X syndrome. J Intellect Disabil Res 2011; 55:19-29.
9. Heilman KJ, Harden ER, Zageris DM, et al. Autonomic regulation in Fragile X syndrome. Dev Psychobiol 2011; 53:785-795.
10. Gabis LV, Baruch YK, Jokel A, Raz R. Psychiatric and autistic comor-bidity in Fragile X syndrome across ages. J Child Neurol 2011; 26:940-948.
11. Morris CA. The behavioral phenotype of Williams syndrome: a recognizable pattern of neurodevelopment. Am J Med Genet C Semin Med Genet 2010; 154C:427-431.
12. Plesa Skwerer D, Ammerman E, Andre MC, et al. A multimeasure approach to investigating affective appraisal of social information in Williams syndrome. J Neurodev Disord 2011; 3:325-334.
13. Siegel MS, Smith WE. Psychiatric features in children with genetic syndromes: toward functional phenotypes. Pediatr Clin North Am 2011; 58:833-864; x.
14. Jarvinen-Pasley A, Bellugi U, Reilly J, et al. Defining the social phenotype in Williams syndrome: a model for linking gene, the brain, and behavior. Dev Psychopathol 2008; 20:1-35. (Pubitemid 351166704)
15. Feinstein C, Singh S. Social phenotypes in neurogenetic syndromes. Child Adolesc Psychiatr Clin North Am 2007; 16:631-647. (Pubitemid 46880403)
16. Watson C, Hoeft F, Garrett AS, et al. Aberrant brain activation during gaze processing in boys with Fragile X syndrome. Arch Gen Psychiatry 2008; 65:1315-1323.
17. Capitao L, Sampaio A, Fernandez M, et al. Williams syndrome hypersocia-bility: a neuropsychological study of the amygdala and prefrontal cortex hypotheses. Res Dev Disabil 2011; 32:1169-1179.
18. Dodd HF, Porter MA, Peters GL, Rapee RM. Social approach in preschool children with Williams syndrome: the role of the face. J Intellect Disabil Res 2010; 54:194-203.
19. Jawaid A, Riby DM, Egridere S, et al. Approachability in Williams syndrome. Neuropsychologia 2010; 48:1521-1523.
20. Riby DM, Jones N, Brown PH, et al. Attention to faces in Williams syndrome. J Autism Dev Disord 2011; 41:1228-1239.
21. Dodd HF, Porter MA. I see happy people: attention bias towards happy but not angry facial expressions in Williams syndrome. Cogn Neuropsychiatry 2010; 15:549-567.
22. Dodd HF, Porter MA. Interpretation of ambiguous situations: evidence for a dissociation between social and physical threat in Williams syndrome. J Autism Dev Disord 2011; 41:266-274.
23. Dodd HF, Schniering CA, Porter MA. Beyond behaviour: is social anxiety low in Williams syndrome? J Autism Dev Disord 2009; 12:1673-1681.
24. Hoeft F, Walter E, Lightbody AA, et al. Neuroanatomical differences in toddler boys with Fragile X syndrome and idiopathic autism. Arch Gen Psychiatry 2011; 68:295-305.
25. Gothelf D, Furfaro JA, Hoeft F, et al. Neuroanatomy of Fragile X syndrome is associated with aberrant behavior and the Fragile X mental retardation protein (FMRP). Ann Neurol 2008; 63:40-51. (Pubitemid 351240550)
26. Reiss AL, Eckert MA, Rose FE, et al. An experiment of nature: brain anatomy parallels cognition and behavior in Williams syndrome. J Neurosci 2004; 24:5009-5015. (Pubitemid 38697834)
27. Capitao L, Sampaio A, Sampaio C, et al. MRI amygdala volume in Williams Syndrome. Res Dev Disabil 2011; 32:2767-2772.
28. Haas BW, Mills D, Yam A, et al. Genetic influences on sociability: heightened amygdala reactivity and event-related responses to positive social stimuli in Williams syndrome. J Neurosci 2009; 29:1132-1139.
29. Meyer-Lindenberg A, Hariri AR, Munoz KE, et al. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci 2005; 8:991-993. (Pubitemid 41061508)
30. Hallahan BP, Craig MC, Toal F, et al. In vivo brain anatomy of adult males with Fragile X syndrome: an MRI study. Neuroimage 2011; 54:16-24.
31. Golarai G, Hong S, Haas BW, et al. The fusiform face area is enlarged in Williams syndrome. J Neurosci 2010; 30:6700-6712.
32. Garrett AS, Menon V, MacKenzie K, Reiss AL. Here's looking at you, kid: neural systems underlying face and gaze processing in Fragile X syndrome. Arch Gen Psychiatry 2004; 61:281-288. (Pubitemid 38295830)
33. Mimura M, Hoeft F, Kato M, et al. A preliminary study of orbitofrontal activation and hypersociability in Williams Syndrome. J Neurodev Disord 2010; 2:93-98.
34. Menon V, Leroux J, White CD, Reiss AL. Frontostriatal deficits in Fragile X syndrome: relation toFMR1 gene expression. Proc Natl Acad Sci USA 2004; 101:3615-3620. (Pubitemid 38338243)
35. Hoeft F, Hernandez A, Parthasarathy S, et al. Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with Fragile X syndrome. Hum Brain Mapp 2007; 28:543-554. (Pubitemid 46849370)
36. Frigerio E, Burt DM, Gagliardi C, et al. Is everybody always my friend? Perception of approachability in Williams syndrome. Neuropsychologia 2006; 44:254-259. (Pubitemid 41740752)
37. Scerif G, Cornish K, Wilding J, et al. Visual search in typically developing toddlers and toddlers with Fragile X or Williams syndrome. Dev Sci 2004; 7:116-130. (Pubitemid 38213662)
38. Haas BW, Barnea-Goraly N, Lightbody AA, et al. Early white-matter abnormalities of the ventral frontostriatal pathway in Fragile X syndrome. Dev Med Child Neurol 2009; 51:593-599.
39. Mobbs D, Eckert MA, Mills D, et al. Frontostriatal dysfunction during response inhibition in Williams syndrome. Biol Psychiatry 2007; 62:256-261. (Pubitemid 47042015)
40. Bray S, Hirt M, Jo B, et al. Aberrant frontal lobe maturation in adolescents with Fragile X syndrome is related to delayed cognitive maturation. Biol Psychiatry 2011; 70:852-858.
41. Hoeft F, Lightbody AA, Hazlett HC, et al. Morphometric spatial patterns differentiating boys with Fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. Arch Gen Psychiatry 2008; 65:1087-1097.
42. Hoeft F, Carter JC, Lightbody AA, et al. Region-specific alterations in brain development in one-to three-year-old boys with Fragile X syndrome. Proc Natl Acad Sci USA 2010; 107:9335-9339.
43. Hazlett HC, Poe MD, Lightbody AA, et al. Teasing apart the heterogeneity of autism: Same behavior, different brains in toddlers with Fragile X syndrome and autism. J Neurodev Disord 2009; 1:81-90.
44. Campbell LE, Daly E, Toal F, et al. Brain structural differences associated with the behavioural phenotype in children with Williams syndrome. Brain Res 2009; 1258:96-107.
45. Chiang MC, Reiss AL, Lee AD, et al. 3D pattern of brain abnormalities in Williams syndrome visualized using tensor-based morphometry. Neuroimage 2007; 36:1096-1109. (Pubitemid 47007716)
46. Vicari S, Bellucci S, Carlesimo GA. Visual and spatial long-term memory: differential pattern of impairments in Williams and Down syndromes. Dev Med Child Neurol 2005; 47:305-311. (Pubitemid 40662869)
47. Hocking DR, Rinehart NJ, McGinley JL, et al. Gait adaptation during obstacle crossing reveals impairments in the visual control of locomotion in Williams syndrome. Neuroscience 2011; 197:320-329.
48. Hocking DR, Rinehart NJ, McGinley JL, et al. A kinematic analysis of visually-guided movement in Williams syndrome. J Neurol Sci 2011; 301:51-58.
49. Kogan CS, Bertone A, Cornish K, et al. Integrative cortical dysfunction and pervasive motion perception deficit in Fragile X syndrome. Neurology 2004; 63:1634-1639. (Pubitemid 39507581)
50. Kogan CS, Boutet I, Cornish K, et al. Differential impact of the FMR1 gene on visual processing in Fragile X syndrome. Brain 2004; 127 (Pt 3):591-601. (Pubitemid 38295475)
51. Hoeft F, Barnea-Goraly N, Haas BW, et al. More is not always better: increased fractional anisotropy of superior longitudinal fasciculus associated with poor visuospatial abilities in Williams syndrome. J Neurosci 2007; 27:11960-11965. (Pubitemid 350072122)
52. Marenco S, Siuta MA, Kippenhan JS, et al. Genetic contributions to white matter architecture revealed by diffusion tensor imaging in Williams syndrome. Proc Natl Acad Sci USA 2007; 104:15117-15122. (Pubitemid 47619602)
53. Kwon H, Menon V, Eliez S, et al. Functional neuroanatomy of visuospatial working memory in Fragile X syndrome: relation to behavioral and molecular measures. Am J Psychiatry 2001; 158:1040-1051. (Pubitemid 32623107)
54. Meyer-Lindenberg A, Kohn P, Mervis CB, et al. Neural basis of genetically determined visuospatial construction deficit in Williams syndrome. Neuron 2004; 43:623-631. (Pubitemid 39179723)
55. Lasker AG, Mazzocco MM, Zee DS. Ocular motor indicators of executive dysfunction in Fragile X and Turner syndromes. Brain Cogn 2007; 63:203-220. (Pubitemid 46371477)
56. Winter M, Pankau R, Amm M, et al. The spectrum of ocular features in the Williams-Beuren syndrome. Clin Genet 1996; 49:28-31. (Pubitemid 26090409)
57. Atkinson J, Anker S, Braddick O, et al. Visual and visuospatial development in young children with Williams syndrome. Dev Med Child Neurol 2001; 43:330-337. (Pubitemid 32457835)
58. Van der Geest JN, Lagers-van Haselen GC, van Hagen JM, et al. Visual depth processing in Williams-Beuren syndrome. Exp Brain Res 2005; 166:200-209. (Pubitemid 41406811)
59. Van der Geest JN, Lagers-van Haselen GC, van Hagen JM, et al. Saccade dysmetria in Williams-Beuren syndrome. Neuropsychologia 2004; 42:569-576. (Pubitemid 38064281)
60. Barnea-Goraly N, Eliez S, Hedeus M, et al. White matter tract alterations in Fragile X syndrome: preliminary evidence from diffusion tensor imaging. Am J Med Genet B Neuropsychiatr Genet 2003; 118B:81-88. (Pubitemid 37064081)
61. Menghini D, Di Paola M, Federico F, et al. Relationship between brain abnormalities and cognitive profile in Williams syndrome. Behav Genet 2011; 41:394-402.
62. Reiss AL, Eckert MA, Rose FE, et al. An experiment of nature: brain anatomy parallels cognition and behavior in Williams syndrome. J Neurosci 2004; 24:5009-5015. (Pubitemid 38697834)
63. Rhodes SM, Riby DM, Fraser E, Campbell LE. The extent of working memory deficits associated with Williams syndrome: Exploration of verbal and spatial domains and executively controlled processes. Brain Cogn 2011; 77:208-214.
64. Fishman I, Yam A, Bellugi U, Mills D. Language and sociability: insights from Williams syndrome. J Neurodev Disord 2011; 3:185-192.
65. Mostofsky SH, Mazzocco MM, Aakalu G, et al. Decreased cerebellar posterior vermis size in Fragile X syndrome: correlation with neurocognitive performance. Neurology 1998; 50:121-130.
66. Sampaio A, Sousa N, Fernandez M, et al. MRI assessment of superior temporal gyrus in Williams syndrome. Cogn Behav Neurol 2008; 21:150-156.
67. Schmitt JE, Eliez S, Warsofsky IS, et al. Enlarged cerebellar vermis in Williams syndrome. J Psychiatr Res 2001; 35:225-229. (Pubitemid 32913030)
68. Bray S, Hirt M, Jo B, et al. Aberrant frontal lobe maturation in adolescents with Fragile X syndrome is related to delayed cognitive maturation. Biol Psychiatry 2011; 70:852-858.
69. Tamm L, Menon V, Johnston CK, Hessl DR. Reiss AL. fMRI study of cognitive interference processing in females with Fragile X syndrome. J Cogn Neurosci 2002; 14:160-171. (Pubitemid 34113703)
70. Eckert MA, Hu D, Eliez S, et al. Evidence for superior parietal impairment in Williams syndrome. Neurology 2005; 64:152-153. (Pubitemid 40082957)
71. Abbeduto L, Brady N, Kover ST. Language development and Fragile X syndrome: profiles, syndrome-specificity, and within-syndrome differences. Ment Retard Dev Disabil Res Rev 2007; 13:36-46. (Pubitemid 46399473)
72. Pierpont EI, Richmond EK, Abbeduto L, et al. Contributions of phonological and verbal working memory to language development in adolescents with Fragile X syndrome. J Neurodev Dis 2011; 3:335-347.
73. Baker S, Hooper S, Skinner M, et al. Working memory subsystems and task complexity in young boys with Fragile X syndrome. J Intellect Disabil Res 2011; 55:19-29.
74. Munir F, Cornish KM, Wilding J. Nature of the working memory deficit in Fragile-X syndrome. Brain Cogn 2000; 44:387-401. (Pubitemid 32001410)
75. Menghini D, Addona F, Costanzo F, Vicari S. Executive functions in individuals with Williams syndrome. J Intellect Disabil Res 2010; 54:418-432.
76. Wager TD, Smith EE. Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci 2003; 3:255-274. (Pubitemid 40214833)
77. Ellegood J, Pacey LK, Hampson DR, et al. Anatomical phenotyping in a mouse model of Fragile X syndrome with magnetic resonance imaging. Neuroimage 2010; 53:1023-1029.
78. Greco CM, Navarro CS, Hunsaker MR, et al. Neuropathologic features in the hippocampus and cerebellum of three older men with Fragile X syndrome. Mol Autism 2011; 2:2.
79. Zhang A, Shen CH, Ma SY, et al. Altered expression of autism-associated genes in the brain of Fragile X mouse model. Biochem Biophys Res Commun 2009; 379:920-923.
80. Edbauer D, Neilson JR, Foster KA, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010; 65:373-384.
81. Muddashetty RS, Kelic S, Gross C, et al. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of Fragile X syndrome. J Neurosci 2007; 27:5338-5348. (Pubitemid 46790157)
82. Krueger DD, Osterweil EK, Chen SP, et al. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of Fragile X syndrome. Proc Natl Acad Sci USA 2011; 108:2587-2592.
83. Schutt J, Falley K, Richter D, et al. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in post-synaptic densities. J Biol Chem 2009; 284:25479-25487.
84. Dictenberg JB, Swanger SA, Antar LN, et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to Fragile X syndrome. Dev Cell 2008; 14:926-939. (Pubitemid 351757204)
85. Adusei DC, Pacey LK, Chen D, Hampson DR. Early developmental alterations in GABAergic protein expression in Fragile X knockout mice. Neuro-pharmacology 2010; 59:167-171.
86. Miyashiro KY, Beckel-Mitchener A, Purk TP, et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 2003; 37:417-431. (Pubitemid 36183364)
87. Zhu ZW, XuQ, Zhao ZY, et al. Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain. Neuropathology 2011; 31:223-229.
88. Westmark CJ, Malter JS. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 2007; 5:e52.
89. Park S, Park JM, Kim S, et al. Elongation factor 2 and Fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 2008; 59:70-83. (Pubitemid 351905855)
90. D'Hulst C, Heulens I, Brouwer JR, et al. Expression of the GABAergic system in animal models for Fragile X syndrome and Fragile X associated tremor/ataxia syndrome (FXTAS). Brain Res 2009; 1253:176-183.
91. Dahlhaus R, El-Husseini A. Altered neuroligin expression is involved in social deficits in a mouse model of the Fragile X syndrome. Behav Brain Res 2010; 208:96-105.
92. Olmos-Serrano JL, Paluszkiewicz SM, Martin BS, et al. Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of Fragile X syndrome. J Neurosci 2010; 30:9929-9938.
93. Menon L, Mader SA, Mihailescu MR. Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA. RNA 2008; 14:1644-1655.
94. Liao L, Park SK, Xu T, et al. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci USA 2008; 105:15281-15286.
95. Tamamaki N, Fujimori K, Nojyo Y, et al. Evidence that Sema3A and Sema3F regulate the migration of GABAergic neurons in the developing neocortex. J Comp Neurol 2003; 455:238-248. (Pubitemid 35424260)
96. Harlow EG, Till SM, Russell TA, et al. Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron 2010; 65:385-398.
97. Deng PY, Sojka D, Klyachko VA. Abnormal presynaptic short-term plasticity and information processing in a mouse model of Fragile X syndrome. J Neurosci 2011; 31:10971-10982.
98. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439:283-289. (Pubitemid 43128846)
99. Yang EJ, Yoon JH, Min DS, Chung KC. LIM kinase 1 activates cAMP-responsive element-binding protein during the neuronal differentiation of immortalized hippocampal progenitor cells. J Biol Chem 2004; 279:8903-8910. (Pubitemid 38295951)
100. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003; 2:255-267. (Pubitemid 37345664)
101. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of Fragile X mental retardation. Proc Natl Acad Sci US A 2002; 99:7746-7750. (Pubitemid 34568762)
102. Chowdhury S, Shepherd JD, Okuno H, et al. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 2006; 52:445-459. (Pubitemid 44667430)
103. Jeon SJ, Seo JE, Yang SI, et al. Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascades. J Biomed Sci 2011; 18:17.
104. Dahlhaus R, Hines RM, Eadie BD, et al. Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus. Hippocampus 2010; 20:305-322.
105. Greicius MD, Boyett-Anderson JM, Menon V, Reiss AL. Reduced basal forebrain and hippocampal activation during memory encoding in girls with Fragile X syndrome. Neuroreport 2004; 15:1579-1583. (Pubitemid 38971175)
106. Feyder M, Karlsson RM, Mathur P,et al. Associationof mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry 2010; 167:1508-1517.
107. Thomas AM, Bui N, Perkins JR, et al. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for Fragile X syndrome. Psychopharmacology 2011; 219:47-58.
108. Burket JA, Herndon AL, Winebarger EE, et al. Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: Possible implications for the pharmacotherapy of autism spectrum disorders. Brain Res Bull 2011; 86:152-158.
109. Lindemann L, Jaeschke G, Michalon A, et al. CTEP: a novel, potent, long-acting and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J Pharmacol Exp Ther 2011; 339:474-486.
110. Levenga J, Hayashi S, de Vrij FM, et al. AFQ056, a new mGluR5 antagonist for treatment of Fragile X syndrome. Neurobiol Dis 2011; 42:311-317.
111. Veeraragavan S, Bui N, Perkins JR, et al. Modulation of behavioral pheno-types byamuscarinic M1antagonistin a mouse model of FragileX syndrome. Psychopharmacology 2011; 217:143-151.
112. Veeraragavan S, Bui N, Perkins JR, et al. The modulation of Fragile X behaviors by the muscarinic M4 antagonist, tropicamide. Behav Neurosci 2011; 125:783-790.
113. Olmos-Serrano JL, Corbin JG, Burns MP. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of Fragile X syndrome. Dev Neurosci 2011; 33:395-403.
114. Erickson CA, Mullett JE, McDougle CJ. Brief report: acamprosate in Fragile X syndrome. J Autism Dev Disord 2010; 40:1412-1416.
115. Jacquemont S, Curie A, des Portes V, et al. Epigenetic modification of the FMR1 gene in Fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 2011; 3:64ra1.
116. Erickson CA, Mullett JE, McDougle CJ. Open-label memantine in Fragile X syndrome. J Autism Dev Disord 2009; 39:1629-1635.
117. Kesler SR, Lightbody AA, Reiss AL. Cholinergic dysfunction in Fragile X syndrome and potential intervention: a preliminary 1H MRS study. Am J Med Genet A 2009; 149A:403-407.
118. Erickson CA, Weng N, Weiler IJ, et al. Open-label riluzole in Fragile X syndrome. Brain Res 2011; 1380:264-270.
119. Torrioli M, Vernacotola S, Setini C, et al. Treatment with valproic acid ameliorates ADHD symptoms in Fragile X syndrome boys. Am J Med Genet A 2010; 152A:1420-1427.
120. Su T, Fan HX, Jiang T, et al. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for Fragile X syndrome. Psychopharmacology 2011; 215:291-300.
121. Choi CH, Schoenfeld BP, Bell AJ, et al. Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment. Brain Res 2011; 1380:106-119.
122. Paluszkiewicz SM, Martin BS, Huntsman MM. Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev Neurosci 2011; 33:349-364.
123. Poitras L, Yu M, Lesage-Pelletier C, et al. An SNP in an ultraconserved regulatory element affects Dlx5/Dlx6 regulation in the forebrain. Development 2010; 137:3089-3097.
124. Menon L, Mihailescu MR. Interactions of the G quartet forming semaphorin 3F RNA with the RGG box domain of the Fragile X protein family. Nucleic Acids Res 2007; 35:5379-5392. (Pubitemid 47423912)
125. Le TN, Du G, Fonseca M, et al. Dlx homeobox genes promote cortical interneuron migration from the basal forebrain by direct repression of the semaphorin receptor neuropilin-2. J Biol Chem 2007; 282:19071-19081. (Pubitemid 47100172)
126. Grossman AW, Aldridge GM, Lee KJ, et al. Developmental characteristics of dendritic spinesin the dentate gyrusofFmr1 knockout mice. Brain Res 2010; 1355:221-227.
127. Galvez R, Smith RL, Greenough WT. Olfactory bulb mitral cell dendritic pruning abnormalities in a mouse model of the Fragile-X mental retardation syndrome: further support for FMRP's involvement in dendritic development. Brain Res Dev Brain Res 2005; 157:214-216. (Pubitemid 40800422)
128. Bennett BD, Callaway JC, Wilson CJ. Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J Neurosci 2000; 20:8493-8503.
129. Hessl D, Rivera SM, Reiss AL. The neuroanatomy and neuroendocrinology of Fragile X syndrome. Ment Retard Dev Disabil Res Rev 2004; 10:17-24. (Pubitemid 38375349)
130. Laumonnier F, Roger S, Guerin P, et al. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am J Psychiatry 2006; 163:1622-1629. (Pubitemid 44465764)
131. Volk LJ, Pfeiffer BE, Gibson JR, Huber KM. Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in Fragile X syndrome mental retardation. J Neurosci 2007; 27:11624-11634. (Pubitemid 350006892)
132. Chang S, Bray SM, Li Z, et al. Identification of small molecules rescuing Fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 2008; 4:256-263. (Pubitemid 351419125)
133. D'Antuono M, Merlo D, Avoli M. Involvement of cholinergic and gabaergic systems in the Fragile X knockout mice. Neuroscience 2003; 119:9-13. (Pubitemid 36577406)
134. Pacey LK, Tharmalingam S, Hampson DR. Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in Fragile X syndrome. J Pharmacol Exp Ther 2011; 338:897-905.
135. Rives ML, Vol C, Fukazawa Y, et al. Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J 2009; 28:2195-2208.
136. Campbell LE, Daly E, Toal F, et al. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 2006; 129 (Pt 5):1218-1228.
137. Kates WR, Burnette CP, Bessette BA, et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol 2004; 19:337-342. (Pubitemid 38867944)